SecBot SecBot
SECBOTREPLAY Home › Report › NTRA

NTRA · Two C-suite executives at Natera (President of Clinical Diagnostics and…

Natera, Inc. · CLUSTER filed Apr 26, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Apr 26, 2026 at 20:00 ET

Two C-suite executives at Natera (President of Clinical Diagnostics and President/Chief Business Officer) sold a combined $360K in open-market sales on April 27, 2026, at $203.75 per share. This follows a broader cluster of insider selling by the CEO, directors, and other officers totaling ~$1.5M over the prior week. While the dollar amount is trivial relative to Natera's $28.6B market cap (0.0013%), the concentration of selling by senior leadership near the stock's recent highs warrants attention.

  • President of Clinical Diagnostics Solomon Moshkevich sold 997 shares for $203K on April 27
  • President and Chief Business Officer John Fesko sold 771 shares for $157K on April 27
  • Total open-market sales in this cluster: $360K
  • Prior week saw CEO Steven Chapman sell $463K and other insiders sell $680K

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access